STXS
HEALTHCAREStereotaxis Inc
$1.92+0.00 (+0.00%)LIVE
Live · AMEX · May 9, Close
AI Insight
What's Moving STXS Today?
No stock-specific AI insight has been generated for STXS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.74$3.59
$1.92
Fundamentals
Market Cap$187M
P/E Ratio—
EPS$-0.25
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume300K
Avg Volume (10D)—
Shares Outstanding97.5M
STXS News
20 articles- Inogen (INGN) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Integra LifeSciences (IART) Beats Q1 Earnings and Revenue EstimatesYahoo Finance·May 5, 2026
- Why Stereotaxis (STXS) Could Be One of the Best Robotics Stocks to Buy Under $30Yahoo Finance·May 1, 2026
- Stereotaxis Stock Up on First U.S. MAGiC Procedures Post ApprovalYahoo Finance·Apr 23, 2026
- Stereotaxis Announces First MAGiC Procedures in the United StatesYahoo Finance·Apr 22, 2026
- Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026Yahoo Finance·Apr 21, 2026
- STXS to Acquire Robocath to Lead in Endovascular Robotics MarketYahoo Finance·Apr 17, 2026
- Stereotaxis to acquire Robocath for up to $45mMedicaldevice-network·Apr 16, 2026
- Stereotaxis Announces Definitive Agreement to Acquire RobocathYahoo Finance·Apr 15, 2026
- Stereotaxis to buy Robocath for up to $45MMedtechdive·Apr 15, 2026
- STXS Gains on FDA Nod for Synchrony System, Expands Digital SurgeryYahoo Finance·Apr 7, 2026
- Stereotaxis Announces FDA Clearance and Launch of Synchrony SystemYahoo Finance·Apr 6, 2026
- Intuitive Surgical Under Pressure in China: Can It Defend Its Position?Yahoo Finance·Apr 2, 2026
- Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ...Yahoo Finance·Mar 10, 2026
- Stereotaxis Q4 Earnings Call HighlightsMarketbeat·Mar 9, 2026
- Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 9, 2026
- Stereotaxis Reports 2025 Full Year Financial ResultsYahoo Finance·Mar 9, 2026
- Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 4, 2026
- Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?Yahoo Finance·Mar 3, 2026
All 20 articles loaded
Price Data
Open$1.95
Previous Close$1.92
Day High$1.96
Day Low$1.89
52 Week High$3.59
52 Week Low$1.74
52-Week Range
$1.74$3.59
$1.92
Fundamentals
Market Cap$187M
P/E Ratio—
EPS$-0.25
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume300K
Avg Volume (10D)—
Shares Outstanding97.5M
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. The company is headquartered in St. Louis, Missouri.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—